Ansbert Gadicke, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 80,789 shares at $27.00 ($2.2M) on 2021-10-01, disclosed to the SEC on 2021-10-05.
Open-market sale of $2.2M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 11,471 | $310K | 14.2% |
| 2 | $27.06 | 34,659 | $938K | 42.9% |
| 3 | $27.06 | 34,659 | $938K | 42.9% |
| Total | $27.05 avg | 80,789 | $2.2M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $20.9M | — | Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-09-23 | $3.1M | — | Filing → |